On September 30, 2026, Sunland BioMed Ltd sold 5.00 million shares of INNOCARE (09969) on the SEHK open market in an on-exchange active trade, representing a direct dealing in the secondary market.
Prior to the disposal, Sunland BioMed Ltd's long position in INNOCARE was 79.33 million shares, representing 4.48%; following the disposal, the holding changed to 74.33 million shares, with the long position ratio falling to 4.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.